Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
ImmunoGen Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Immunogen (IMGN) Prices Upsized 11.64M Share Offering at $6.60/sh
-
ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock
-
Immunogen (IMGN) to Offer $175M in Common Stock
-
ImmunoGen Announces Proposed Public Offering of Common Stock
-
ImmunoGen Announces Webcast of Presentation at Upcoming Canaccord Genuity Virtual Growth Conference
-
Immunogen Inc. (IMGN) PT Lowered to $12 at Canaccord Genuity
-
ImmunoGen Announces Webcast of Presentation at the Canaccord Genuity Growth Conference
-
ImmunoGen Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
ImmunoGen Announces Closing of Public Offering of Common Stock
-
Immunogen (IMGN) Prices Upsized Offering at $11
-
ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock
-
Immunogen (IMGN) Plans 12M Share Offering of Common Stock
-
ImmunoGen Announces Proposed Public Offering of Common Stock
-
Immunogen Inc. (IMGN) PT Raised to $20 at Canaccord Genuity
-
ImmunoGen Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Immunogen (IMGN) Prices 14.5M Share Common Offering at $6.50/Sh
-
ImmunoGen Announces Pricing of Public Offering of Common Stock
-
Pre-Open Movers 10/05: (ONVI) (CERS) (MOBL) Higher; (GSAT) (IMGN) (ECYT) Lower (more...)
-
Immunogen (IMGN) Announces 13M Share Common Offering
-
ImmunoGen Announces Proposed Public Offering of Common Stock
-
ImmunoGen Announces Webcast of Presentation at the Canaccord Genuity Growth Conference
-
ImmunoGen, Inc. Announces Webcasts of Presentations at Upcoming Investor Conferences
-
ImmunoGen, Inc. Announces Canaccord Genuity Growth Conference Webcast
-
Immunogen (IMGN) PT Lifted to $20 at Canaccord Genuity Following IMGN853 ASCO Data
-
Pre-Open Stock Movers 03/23: (MCP) (IMGN) (AAPL) Higher; (MEIP) (VRTX) (NVDA) Lower (more...)
-
Unusual 11 Mid-Day Movers 04/16: (ZLCS) (AKBA) (IMGN) Higher; (XGTI) (AEM) (ZN) Lower
-
UPDATE: Canaccord Genuity Starts Immunogen Inc. (IMGN) at Buy
-
Unusual 11 Mid-Day Movers 11/05: (CYTX) (OXBT) (ENDP) Higher; (DXM) (BSFT) (IMGN) Lower

